Dexcom study shows glucose monitor reduces A1C in type 2 diabetes patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TXN
3. NOW
4. TSLA
5. CSX
6. GOOG
7. IBM
8. KNX
9. LVS
10. INTC

Go back to Dexcom study shows glucose monitor reduces A1C in type 2 diabetes patients
DexCom, Inc. (NASDAQ: DXCM) Delayed: 70.85 -0.58 (0.81%)
Previous Close $71.43    52 Week High $96.38 
Open $71.08    52 Week Low $47.92 
Day High $71.43    P/E N/A 
Day Low $70.50    EPS $-0.42 
Volume 381,903